Use of Knockout Technology to Resolve Pharmacological Problems.
From: Department of Physiology, Royal College of Surgeons in Ireland, 123 St Stephen’s Green, Dublin 2, Ireland. docherty@rcsi.ie
British journal of pharmacology
- Publish Date: Jan 2007
- ISSN: 0007-1188
- Volume: 150
- Issue: 1
- Pages: 1-2
- Medium: Print
- Language: English
- Citation (JAMA): Docherty J R, et al. Use of Knockout Technology to Resolve Pharmacological Problems.. Br. J. Pharmacol. Jan 2007;150:1-2
Abstract
Knock-out (KO) mouse technology has given pharmacologists a powerful tool to study function in the absence of selective antagonists or inhibitors. Such KO technology can confirm predicted function, serendipitously reveal unrecognized function, or help define the mode of action of a drug. In this issue, Liles et al. demonstrate, employing mice unable to synthesize noradrenaline due to the KO of the dopamine-beta-hydroxylase gene, that the sympathomimetic actions of ephedrine are directly, rather than indirectly, mediated. This may end 50 years of debate about the actions of ephedrine.
Mesh Headings (Keywords): Animals, Dopamine beta-Hydroxylase, Mice, Mice, Knockout, Norepinephrine, Pharmacology
Check for Full Text / PubMed Unique Identifier (PMID): 17099720
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.